首页> 外文期刊>Prescrire international >Everolimus (votubia0) for epilepsy associated with tuberous sclerosis complex: Primarily for patients with very troublesome partial seizures
【24h】

Everolimus (votubia0) for epilepsy associated with tuberous sclerosis complex: Primarily for patients with very troublesome partial seizures

机译:everolimus(Votubia0)用于与肺结核硬化复合体相关的癫痫:主要用于患有非常麻烦的部分癫痫发作的患者

获取原文
获取原文并翻译 | 示例
           

摘要

In a double-blind randomised placebo-controlled trial in 366 patients with tuberous sclerosis complex who had frequent partial seizures despite the use of various anti-epileptics, the addition of everolimus reduced seizure frequency. Very few patients became seizure-free. Given its frequent and sometimes severe adverse effects, mainly related to its cytotoxic and immunosuppressive properties, everolimus is only justified for patients with very troublesome frequent partial seizures despite treatment with antiepileptics.
机译:在366例双盲随机安慰剂对照试验中,尽管使用各种抗癫痫作用,但仍有频繁的部分癫痫发作频繁癫痫发作的患者。 很少有患者癫痫发作。 鉴于其频繁且有时严重的不良反应,主要与其细胞毒性和免疫抑制性能有关,尽管用抗癫痫术治疗,但埃弗洛米斯仅针对具有非常麻烦的频繁癫痫发作的患者合理。

著录项

  • 来源
    《Prescrire international》 |2018年第199期|共2页
  • 作者

  • 作者单位
  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号